ASTS
AST SpaceMobile, Inc.
ASTS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow, though they disagree widely on how much.
CYN
Cyngn Inc.
There isn't enough reported data to score CYN yet.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CYN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
CYN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
CYN PE Valuation
CYN has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CYN Forward outlook
There aren't enough analyst estimates for CYN to show an outlook.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
CYN has the stronger earnings trend. Trailing diluted EPS is down 273% for ASTS versus CYN down 135%.
CYN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$3,277.50 | +$6,049.77 |
| Q2 2024 | -$4,966.50 | +$4,442.59 |
| Q1 2024 | -$6,940.91 | +$1,922.73 |
| Q4 2023 | -$8,059.09 | +$395.46 |
CYN is still losing money, but far less than before: $3,277.50 per share over the past year, against $9,409.09 at its worst in mid-2023.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over CYN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS has the edge over CYN on profitability, with a higher operating margin.
CYN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $156.5K | +124% |
| Q2 2026 | $144.5K | +328% |
| Q1 2026 | $104.6K | +122% |
| Q4 2025 | $68.1K | -78% |
| Q3 2025 | $70K | +47% |
| Q2 2025 | $33.7K | +289% |
| Q1 2025 | $47.2K | +755% |
| Q4 2024 | $306.4K | +659% |
CYN's revenue is recovering but still below its 2023 peak: $156,495 last quarter, up 124% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -4093% | +7936 points |
| Q2 2026 | -4675% | +11638 points |
| Q1 2026 | -6638% | +4422 points |
| Q4 2025 | -9621% | -7812 points |
| Q3 2025 | -12029% | -453 points |
| Q2 2025 | -16313% | +50763 points |
| Q1 2025 | -11060% | +97163 points |
| Q4 2024 | -1809% | +11562 points |
CYN's operating margin was −4093% last quarter, up 7936 points from the same quarter a year ago.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
CYN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$5.1M | -$556.9K |
| Q2 2026 | -$5.1M | +$1.4M |
| Q1 2026 | -$8.7M | -$2M |
| Q4 2025 | -$7.1M | -$3.1M |
| Q3 2025 | -$4.6M | +$902.3K |
| Q2 2025 | -$6.4M | -$1.7M |
| Q1 2025 | -$6.7M | -$636.9K |
| Q4 2024 | -$4M | +$1.2M |
CYN has the edge over ASTS on cash flow, with more consistent year-over-year improvement.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has the edge over CYN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
CYN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.3% | +605K shares |
| 1 year | +629% | +12.7M shares |
| 3 years | +642470% | +14.7M shares |
CYN has 15M diluted shares, up 629% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CYN Net Leverage
CYN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
CYN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 25.9 | Oversold |
| Stochastic | 1.2 | Oversold |
CYN's weekly RSI is 26 (oversold) and its Stochastic is 1 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
CYN PE vs Technology Sector
CYN has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over CYN on trend strength, trading above more of its moving averages.
CYN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.45 | 40% below |
| 20 week MA | $0.82 | 67% below |
| 50 week MA | $1.49 | 82% below |
| 100 week MA | $8.94 | 97% below |
| 200 week MA | $2,996.7 | 100% below |
CYN is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS has the edge over CYN on returns for 2026, with the stronger performance.
CYN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $101,590.9 | $65,318.2 | -36% |
| 2022 | $65,318.2 | $8,938.6 | -86% |
| 2023 | $8,938.6 | $2,170.5 | -76% |
| 2024 | $2,170.5 | $94.2 | -96% |
| 2025 | $94.2 | $2.90 | -97% |
| 2026 YTD | $2.90 | $0.27 | -91% |
CYN has finished every year since 2021 lower, and it's down 91% so far in 2026.